Literature DB >> 4363888

Treatment of hyperlipidemia.

R I Levy, J Morganroth, B M Rifkind.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4363888     DOI: 10.1056/NEJM197406062902306

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Treatment of hypertriglyceridaemia after renal transplantation.

Authors:  C Ponticelli; A Cantaluppi; G Barbi; G Annoni; F Mauri
Journal:  Br Med J       Date:  1975-06-14

2.  CORONARY DISEASE-A CHILDHOOD MALADY.

Authors:  Shiela C. Mitchell
Journal:  Cardiovasc Dis       Date:  1975

Review 3.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

4.  Médication et nutrition chez le coronarien.

Authors:  M De Belder
Journal:  Can Fam Physician       Date:  1979-10       Impact factor: 3.275

Review 5.  Clinical pharmacokinetics of hypolipidaemic drugs.

Authors:  R Gugler
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

Review 6.  Choosing the right lipid-regulating agent. A guide to selection.

Authors:  J A Farmer; A M Gotto
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

7.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

8.  Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.

Authors:  M C Bateson; D Maclean; J R Evans; I A Bouchier
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

9.  A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.

Authors:  J I Mann; P A Harding; R C Turner; R H Wilkinson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.